Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine

Vaccine

Volumn 26, Issue 51, 2008, Pages 6569-6576

  Lee, Joo Sub ^a   Kim, Hyun Soo ^b   Seo, Sang Heui ^a  

^a Chungnam National University   (South Korea)

^b Research Institute of Veterinary Medicine   (South Korea)

Author keywords

H9N2; Influenza viruses; Vaccine

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; CD8+ T LYMPHOCYTE; COLD ACCLIMATIZATION; CONTROLLED STUDY; EGG; EGG LAYING; FEMALE; GENETIC ANALYSIS; HEMAGGLUTINATION INHIBITION TEST; HEN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION RESISTANCE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H9N2; INTERFERON PRODUCTION; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; CHICKENS; COLD TEMPERATURE; EGGS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MUTATION; VACCINES, ATTENUATED;

EID: 58149133932     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.043     Document Type: Article

References (32)

1. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 56 1 (1992) 152-179
2. Cameron K.R., Gregory V., Banks J., Brown H., Alexander D.J., Hay A.J., et al. H9N2 subtype influenza A viruses in poultry in Pakistan are closely related to the H9N2 viruses responsible for human infection in Hong Kong. Virology 278 (2000) 36-41
3. Guan Y., Shortridge K.F., Krauss S., and Webster R.G. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?. Proc Natl Acad Sci U S A 96 (1999) 9363-9367
4. Guan Y., Shortridge K.F., Krauss S., Chin P.S., Dyrting K.C., Ellis T.M., et al. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol 74 (2000) 9372-9380
5. Guo Y.J., Krauss S., Senne D.A., Mo I.P., Lo K.S., Xiong X.P., et al. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267 (2000) 279-288
6. Lee C.W., Song C.S., Lee Y.J., Mo I.P., Garcia M., Suarez D.L., et al. Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96. Avian Dis 44 (2000) 527-535
7. Choi Y.K., Seo S.H., Kim J.A., Webby R.J., and Webster R.G. Avian influenza viruses in Korean live poultry markets and their pathogenic potential. Virology 332 (2005) 529-537
8. Macadam A.J., Ferguson G., Stone D.M., Meredith J., Knowlson S., Auda G., et al. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol 80 17 (2006) 8653-8663
9. Roeder P.L., Lubroth J., and Taylor W.P. Experience with eradicating rinderpest by vaccination. Dev Biol (Basel) 119 (2004) 73-91
10. Senne D.A., King D.J., and Kapczynski D.R. Control of Newcastle disease by vaccination. Dev Biol (Basel) 119 (2004) 165-170
11. Veits J., Lüschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., et al. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84 Pt 12 (2003) 3343-3352
12. Nair V. Successful control of Marek's disease by vaccination. Dev Biol (Basel) 119 (2004) 147-154
13. Zhdanov VM. Live influenza vaccines in USSR: development and practical application. In: Kendal A, Patriarca P, editors. Options for the control of influenza, UCLA Symposia on Molecular and Cellular Biology, no. 36. New York: A.R. Liss. 1999; p. 193-205.
14. Alexandrova G.I., Polezhaev F.I., Budilovsky G.N., Garmashova L.M., Topuria N.A., Egorov A.Y., et al. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun 44 3 (1984) 734-739
15. Ghendon Y.Z., Polezhaev F.I., Lisovskaya K.V., Medvedeva T.E., Alexandrova G.I., and Klimov A.I. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun 44 3 (1984) 730-733
16. Maassab H.F. Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature 213 (1967) 612-614
17. Davenport F.M., Hennessy A.V., Maassab H.F., Minuse E., Clark L.C., Abrams G.D., et al. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J Infect Dis 136 1 (1977) 17-25
18. Monto A.S., Miller F.D., and Maassab H.F. Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis 145 1 (1982) 57-64
19. Belshe R.B. Current status of live attenuated influenza virus vaccine in the US. Virus Res 103 1-2 (2004) 177-185
20. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 27 (1938) 493-497
21. Kim J.A., Cho S.H., Kim H.S., and Seo S.H. H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers. Vet Microbiol 118 3-4 (2006) 169-176
22. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C.F., et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306 1 (2003) 18-24
23. Klimov A.I., Cox N.J., Yotov W.V., Rocha E., Alexandrova G.I., and Kendal A.P. Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. Virology 186 2 (1992) 795-797
24. Cox N.J., Kitame F., Kendal A.P., Maassab H.F., and Naeve C. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 167 2 (1988) 554-567
25. Klimov AI. In: Osterhaus ADME, Cox N, Hampson AW, editors. Options for the Control of Influenza IV. International Congress Series, vol. 1219. Amsterdam: Elsevier Science BV; 2001. p. 955-9.
26. Snyder M.H., Betts R.F., DeBorde D., Tierney E.L., Clements M.L., Herrington D., et al. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol 62 2 (1988) 488-495
27. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., and Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8 6 (1998) 683-691
28. McMichael A.J., Gotch F.M., Noble G.R., and Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 309 1 (1983, Jul 7) 13-17
29. Seo S.H., Peiris M., and Webster R.G. Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon. J Virol 76 10 (2002) 4886-4890
30. Chen H., Matsuoka Y., Swayne D., Chen Q., Cox N.J., Murphy B.R., et al. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine 21 27-30 (2003) 4430-4436
31. Rudenko L.G., Slepushkin A.N., Monto A.S., Kendal A.P., Grigorieva E.P., Burtseva E.P., et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod. Russ J Infect Dis 168 4 (1993) 881-887
32. Song H., Nieto G.R., and Perez D.R. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 81 17 (2007) 9238-9248